Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel-Reference-Cited by-同舟云学术

Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel

Published:2018-04 Issue: Volume:419 Page:233-244
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Jin Ying,Hu Wenquan,Liu Tong,Rana Ujala,Aguilera-Barrantes Irene,Kong Amanda,Kumar Suresh N.,Wang Bei,Gao Pin,Wang Xiang,Duan Yajun,Shi Aiping,Song Dong,Yang Ming,Li Sijie,Han Bing,Zhao Gang,Fan Zhimin,Miao Qing Robert^ORCID

Funder

Medical College of Wisconsin

American Cancer Society

We Care Fund and Children's Hospital of Wisconsin Research Institute Pilot Innovative Research

National Natural Science Foundation of China

Bethune Program B of Jilin University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Endocrine therapy of breast cancer;Lumachi;Curr. Med. Chem.,2011

2. Cancer statistics, 2017;Siegel;Ca - Cancer J. Clin.,2017

3. Relevance of pathological complete response after neoadjuvant therapy for breast cancer;Pennisi;Breast Cancer Basic Clin. Res.,2016

4. Treatment of estrogen receptor-positive breast cancer;Lumachi;Curr. Med. Chem.,2013

5. Treatment of breast cancer;Hortobagyi;N. Engl. J. Med.,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Reticulon-4 3-bp Deletion/Insertion Polymorphism Is Associated with Structural mRNA Changes and the Risk of Breast Cancer: A Population-Based Case–Control Study with Bioinformatics Analysis;Life;2023-07-12

2. Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway;Cancer Gene Therapy;2022-10-14

3. Activatable “Matryoshka” nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer;Materials Today Bio;2022-03

4. NOGOB receptor–mediated RAS signaling pathway is a target for suppressing proliferating hemangioma;JCI Insight;2021-02-08

5. Research advances on neurite outgrowth inhibitor B receptor;Journal of Cellular and Molecular Medicine;2020-06-15